Polymer Capital Management (US) LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1973324
NEW YORK, NY
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$425,957
-$794,828 QoQ
Shares Held
1,415
-53.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#498
of 784 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polymer Capital Management (US) LLC holds $5,718,267 across 19 Biotechnology names. ALNY ranks #8 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
|
7,607 | $795,844 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,940 | $649,492 | |
| 3 | RPRX |
Royalty Pharma plc
|
9,552 | $535,580 | |
| 4 | MRNA |
Moderna, Inc.
|
7,002 | $490,350 | |
| 5 | INSM |
INSMED Inc
|
4,537 | $483,734 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
772 | $481,372 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,056 | $438,326 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,415 | $425,957 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $425,957 | 1,415 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,220,785 | 3,070 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $368,448 | 808 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $259,489 | 961 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||